Federal University of Rio de Janeiro (UFRJ), Duque de Caxias Campus Prof. Geraldo Cidade. Rodovia Washington Luiz, 19,593 km 104.5 - Santa Cruz da Serra, CEP 25240-005, Duque de Caxias, RJ, Brazil.
PhD in Plant Biotecology (UFRJ, 2012). Master in Tropical Forest Ecology (INPA, 2002). Post-doctorate in Biochemistry. Specialist in Innovation Management in Phytomedicines (NGBS-Farmanguinhos/FIOCRUZ, 2013). Degree in Biological Sciences (UFRJ, 1999). She was Professor of Innovation for Biotechnology at the Federal University of Amazonas (UFAM). She was CEO of the BioF Digitalization and Training Company in Sustainable Projects. She worked at FIOCRUZ / Farmanguinhos-Central Tecnológica de Medicamentos, as a Technologist in Development of Phytotherapeutics. She worked at INOVA UFRJ in Mapping Technologies and Skills and in Technology Transfer between Science and Technology Institution (ICT) and Company. Research Themes: Conservation of Brazilian Biodiversity. Ecology. Intellectual Property, Geographical Indications, Biotechnology, Innovation and Traditional Knowledge. It operates by supporting sustainable and inclusive development, based on biodiversity, through Bioeconomy strategies, prioritizing initiatives that associate bioindustries installed within territories, with partnerships and a cooperation network for biotechnological prospecting and the transfer of technology to society. She served as Visiting Professor of the Postgraduate Program in Biotechnology (PPG-BIOTEC / BIONORTE) at the Federal University of Amazonas (2019-2020). She was Coordinator of RedesFito, Professor and advisor of the Postgraduate Course on "Management in Phytomedicine Innovation". She worked at the State Secretariat of Science and Technology of Amazonas as Head of the Department of Support for Research and Technological Innovation (2005-2007). Develops projects in the areas of: Environmental Conservation and Recovery, Biotechnological Prospecting, Technology Transfer, Ethnoecology, Socio-environmental Sustainability with Indigenous, Riverine, Caiçaras and Quilombolas and Management in the areas of Natural Sciences, focusing on Biotechnology, and Innovation for National Health. She participates in the Brazilian Academic Consortium for Integrative Health (CABSIN) - Member of the Natural Products Committee, and in RedesFito / Fiocruz. It has been developing partnerships and services since 2004 for institutions such as: ABIFINA, IPAM, UFRJ, INPA, UFAM, SEDECTI/AM, GIZ, COPPETEC, FAPEAM, FAPESBA, PDPI, Amazon Doors, RedeBIONORTE, FQM, OIBI, FOIRN, FUNAI, MDR, MMA , SEDUC/AM, FAS, etc.
Drª Cristina Dislich Ropke
Phytobios Ltda. Avenida Dr. Marcos Penteado de Ulhôa Rodrigues, 1119, room 607, Tamboré, CEP 05508-900, São Paulo, SP, Brazil.
Director of Innovation at the Centroflora Group and CEO of Phytobios Pesquisa Desenvolvimento e Inovação Ltda, a Biodiversity-Based Technological Innovation company. Bachelor's, Master's and Doctorate in Pharmacy-Biochemistry. Fluent German and English. Experience in writing projects for government funding and requests for authorization of access to genetic heritage for the purposes of research, bioprospecting and technological development. Inventor of 5 patent applications. Expertise in intellectual property and partnerships with universities and ICTs. Winner of 6 awards from the Brazilian Cosmetology Association and 1 award for Best work from the SOT dermatology section published in Cutaneous and Ocular Toxicology. During her postdoctoral studies, she worked on evaluating natural products to prevent skin cancer. During this period she had 2 Scientific Initiation Orientations and 1 PhD co-supervision and created the subject FBF5780-1-Pharmaceutical strategies for preventing skin damage induced by solar radiation: natural antioxidants for the Postgraduate program at FCF-USP . Tutor of the IEL Inova Talentos Program.Courses at the MIT Sloan School of Management."Developing and Managing a Successful Technology and Product Strategy" and "Fundamentals of Finance for the Technical Executive". Director of Biodiversity at ABIFINA.
Dr. Ana Cláudia Dias de Oliveira
Brazilian Association of Fine Chemical, Biotechnology and Specialty Industries – ABIFINA, Av. Churchill, 129, Room 1201, Centro, CEP 20020-050, Rio de Janeiro, RJ, Brazil; 2PhD Consulting, Rua Marquês de Abrantes, 19, Sala 901, Flamengo, CEP 22230-060, Rio de Janeiro, RJ, Brazil.
Biologist from the Federal Rural University of Rio de Janeiro (1998), with a Master's degree in Biology from the Federal Rural University of Rio de Janeiro (2000), business doctorate (emphasis on Competitive Intelligence and Intellectual Property) from the Federal University of Rio de Janeiro (2008) , PhD in Biotechnology from the Federal University of Rio de Janeiro (2011) and PhD in Intellectual Property and Innovation at the INPI Academy (2022). From March to August 2008 she was a Business Sandwich Doctoral Fellow in the Country from CNPq, working in the Pharmaceutical Industry, prospecting for medicines. In 2007, she was a Pro-Management Fellow at Far-Manguinhos, in the Coordination of Strategic Affairs, working in the area of Intellectual Property and Technological Innovation. He was a Technical Support Fellow in the Biotechnology Area of the Agricultural Research Company of the State of Rio de Janeiro (Pesagro-Rio), with a Faperj Scholarship, from 2005 to 2007. He was a Patent Analyst at ANVISA until 2001 and a visiting specialist at the INCT Project of Neglected Diseases, coordinated by Dr. Carlos Morel (CDTS/FIOCRUZ) in 2016 and 2017. He has experience in the areas of Biotechnology, Intellectual Property, Innovation, and Biodiversity. She is currently a freelance consultant for entities and companies such as Abifina, Fiocruz, CBPF, INT, LNCC, CETEM, UFRJ, Phytobios, Centroflora and others and a collaborating professor on the Specialization Course in Innovation Management at Fiocruz.
Dr. Celso Luiz Salgueiro Lage
National Institute of Industrial Property, DICOD - Academia. Praça Mauá 7, Room 1012, Centro, CEP 20081-240, Rio de Janeiro, RJ, Brazil.
He has a degree in Physics from the Federal University of Rio de Janeiro (1984), a master's degree in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro (1989) and a PhD in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro (1995) . Post-doctorate in the Department of Scientific and Technological Policy of the IG of UNICAMP. He is currently a Senior Specialist in Industrial Property in Biotechnology at INPI. He has experience in the area of Plant Biotechnology, with an emphasis on Tissue Culture, and Intellectual Property in Biotechnology.
Mrs. Barbara Sena Barbosa
Phytobios Ltda. Avenida Dr. Marcos Penteado de Ulhôa Rodrigues, 1119, room 607, Tam-boré, CEP 05508-900, São Paulo, SP, Brazil.
Brazil is a privileged country for its territorial extension and holds 15 to 20% of the global Biodiversity, that is why it is included in the list of megadiverse countries. It has an outstanding potential for product development, based on the natural resources existing in its territory. The national scenario of the Brazilian Pharmaceutical Bioindustry has high technological requirements, imposed by the regulations of the National Health Surveillance Agency (ANVISA). On the other hand, Brazilian environmental legislation is well constituted in terms of characterizing environmental crimes. Law nº. 13.123 of 2015 recognizes the importance of traditional knowledge associated with Brazilian biodiversity and establishes mechanisms for sharing benefits. This whole scenario would be perfect, if it were not for small issues to be understood and corrected, such as the greater integration, valuation and return evaluation of the herbal medicine development chain. There is still time to change this scenario, but we need speed, strategy and efficiency, otherwise we will be burning our genetic library of Amazonian Bioinovative opportunities.
Laird SA. Biodiversidad y Conocimento Tradicional: Participación equitativa en práctica. Fondo Mundial para la Naturaleza (WWF). Editorial Nordan-Comunidad. Montevideo, Uruguay. ISBN (No’dam) 9974-42-102-0. 518p. Jul. 2003. [https://unesdoc.unesco.org/ark:/48223/pf0000227953].
Assad ALD. Políticas públicas para a biotecnologia no Brasil. In: Biotecnologia e (Bio) Negócio no Amazonas/ Organização: Filho GA, Lasmar DJ, Herculano FEB, Pimenta NL. (Org.). - Manaus: EDUA, Pp: 14-37. 2015.
Brasil. Lei nº 10.973, de 02 de dezembro de 2004. Dispõe sobre incentivos à Inovação e a Pesquisa Científica e Tecnológica no Ambiente Produtivo e dá outras providências. Lei de Inovação Brasileira. Brasília- DF. 2004. [acesso em: 12 jun. 2020]. Disponível em: [http://www.planalto.gov.br/ccivil_03/_ato2004-2006/2004/lei/l10.973.htm].
Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Departamento de Atenção Básica. Política Nacional de Práticas Integrativas e Complementares no SUS - PNPIC- SUS / Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Básica. Brasília : Ministério da Saúde, 2006a. [acesso em: 12 jun 2020]. Disponivel em: [http://bvsms.saude.gov.br/bvs/publicacoes/politica_nacional_praticas_integrativas_complementares_2ed.pdf].
Brasil. Relação nacional de medicamentos essenciais: RENAME 2020 [recurso eletrônico] / Ministério da Saúde, Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde, Departamento de Assistência Farmacêutica e Insumos Estratégicos. – Brasília : Ministério Da Saúde, 217p. 2020. [acesso em: 20 jun 2020]. Disponível em: [https://bvsms.saude.gov.br/bvs/publicacoes/relacao_medicamentos_rename_2020.pdf].
Brasil. Ministério de Meio Ambiente – MMA. Medida Provisória nº 2.186, 16 de agosto de 2001, Decreto nº 3.945, de 28 de setembro de 2001. Resolução nº 001, de 8 de julho de 2002. Ministério de Meio Ambiente - MMA/Conselho de Gestão do Patrimônio Genético (Cgen). Brasília – DF. Pg. 47. 2002. [acesso em: 20 jun 2020]. Disponível em: [http://www.planalto.gov.br/ccivil_03/_Ato2015-2018/2015/Lei/L13123.htm#art50].
Brasil. Lei da Biodiversidade nº 13.123. Acesso ao Patrimônio Genético, conhecimento tradicional associado e repartição de benefícios. Regulamentada pelo Decreto no. 8.772, de 11/05/2016. Publicada em 20 de maio de 2015. [acesso em: 25 jun 2020]. Disponível em: [http://www.planalto.gov.br/ccivil_03/_ato2015-2018/2015/lei/l13123.htm].
Cragg GM, Grothaus PG, Newman DJ. Impact of Natural Products on Developing New Anti-Cancer Agents †. Chem Rev. 2009; 109(7): 3012–3043. [https://doi.org/10.1021/cr900019j].
Brasil. Constituição Federal. Coletânea de Legislação de Direito Ambiental. Organização Medauar O. 7ª ed. Rev Atual Ampla. São Paulo: Editora Revista dos Tribunais, ISBN 978-85-203-3018-0. 2008.
Rodrigues DCB. Conhecimentos Tradicionais e Mecanismos de Proteção: estudo de caso nas comunidades de Ebenézer e Mucajá em Maués/AM. Manaus. 2009. Tese de Doutorado. [Programa de Pós-Graduação em Biotecnologia] – Instituto de Ciências Biológicas. Universidade Federal do Amazonas, UFAM, Manaus, AM. 2009. Edua. ISBN 978-85-7401-793-8. 2015. [https://tede.ufam.edu.br/handle/tede/3127].
Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Instrução Normativa nº 4 (18/06/2018). Determina a publicação do Guia de Orientação para registro de medicamento fitoterápico e registro e notificação de Produto Tradicional Fitoterápico. ANVISA. Brasília - DF. 2014. [https://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2014/int0004_18_06_2014.pdf].
Frickmann FSES, Vasconcellos AG. Awakening the Biodiversity Potential Trough ST&I Investments in the Sector of Amazonian Biotechnology. J Technol Managem In-nov. 2013; 8(Special Issue): 239-250. ALTEC: Social and Sustainable Project, Knowledge and Innovation Management. ISSN 0718-2724. [https://doi.org/10.4067/S0718-27242013000300022].
Frickmann FSES. Fatores condicionantes do desenvolvimento biotecnológico da Amazônia brasileira. Rio de Janeiro. 2012. 186p. Tese de Doutorado [Programa de Biotecnologia Vegetal] – Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro. 2012.
SECTI. Cadernos de CT&I Amazonas: empregabilidade de mestres e indicadores de C&T no Amazonas / Secretaria de Estado de Ciência, Tecnologia e Inovação - SECTI; Departamento de Relações Interinstitucionais e Indicadoresde CT&I - DIN. - n. 2 (nov. 2013/jan. 2014) - . - Amazonas: SECTI. ISSN: 2318-4396. 2014.
Weber M. Ciência & Política: duas vocações./18 Ed. São Paulo: Cultrix, ISBN 978-85-316-0047-0. 157p. 2011.
Frickmann FSES, Vasconcellos AG. 2011. Research and patent of phytotherapeutic and phytocosmetic products in the brazilian Amazon. J Technol Managem Innov. 2011; 6: 136-150. ISSN: 0718-2724. [http://dx.doi.org/10.4067/S0718-27242011000400011].
Pimentel V, Vieira V, Mitidieri T, França F, Pieroni JP. Biodiversidade brasileira como fonte da inovação farmacêutica: uma nova esperança? Rev BNDES. Rio de Janeiro. Jun. 2015; 43: 41-89. [https://web.bndes.gov.br/bib/jspui/handle/1408/5602].
Brasil. Presidência da República. Lei nº 9.279, de 14 de maio de 1996. Regulamenta os direitos e obrigações relativos à propriedade industrial. Brasília, 175º da Independência e 108º da República. D.O.U. de 15 de maio de 1996. [acesso em: 07 ago. 2020]. Disponível em: [https://www.planalto.gov.br/ccivil_03/leis/l9279.htm].
Oliveira PJM. Reconhecimento das plantas medicinais de uso tradicional no Brasil: A relevância e o pioneirismo da Casa Granado. Rio de Janeiro. 96p. 2014. Instituto de Tecnologia em Fármacos Farmanguinhos/ Fiocruz. Monografia da Especialização do Curso de Gestão da Inovação em Fitomedicamentos. Rio de Janeiro. [https://www.arca.fiocruz.br/handle/icict/13014].
Brasil. Centro de Gestão e Estudos Estratégicos (CGEE). Diagnóstico dos desafios e oportunidades no mercado de Plantas Medicinais e Fitoterápicos brasileiro. Ciênc Tecnol Inov. Brasília. 2009.
Oliveira ACD, Ropke CD. Os dez anos da Política Nacional de Plantas Medicinais e Fitoterápicos (PNPMF) e os principais entraves da cadeia produtiva de extratos vegetais e medicamentos fitoterápicos no Brasil. Rev Fitos. 2016; 10(2): 185-219. [https://doi.org/10.5935/2446-4775.20160015].
Simões CMO, Schenkel EP, Mello JCP, Mentz LA, Petrovick PR. Farmacognosia do Produto Natural ao Medicamento. Artmed, Porto Alegre, 486p., 2019. ISBN 13: 978-8582713594.
FAPEAM. Pesquisa e Inovação Tecnológica em Empresas: quando a pesquisa é um bom negócio. Secretaria de Estado de Ciência e Tecnologia – SECT. 65p. 2012.
Most read articles by the same author(s)
Daniela Barretto Barbosa Trivella,
Marjorie Christine Paule Bruder,
Fábio Cesar Bonafé Oliveira,
Renata Porcaro,
Joane Kathelen Rustiguel,
Leonardo Bergamasco Ribeiro,
Rafael de Felicio,
Marcos Guilherme da Cunha,
Andrey Fabricio Ziem Nascimento,
Ana Carolina Mattos Zeri,
Lisandra Ravanelli Pessa,
Alessandra Mascarello,
Cristiano Ruch Werneck Guimarães,
Hatylas Azevedo,
Marcia Luana Gomes Perfeito,
Eduardo Pagani,
Cristina Dislich Ropke,
Natural Product-based Drug Discovery and the Molecular Power House (MPH) Approach
,
Revista Fitos: Vol. 16 No. Supl. 2 (2022): Bioprospecção
Dr. Fabiana dos Santos e Souza Frickmann
Federal University of Rio de Janeiro (UFRJ), Duque de Caxias Campus Prof. Geraldo Cidade. Rodovia Washington Luiz, 19,593 km 104.5 - Santa Cruz da Serra, CEP 25240-005, Duque de Caxias, RJ, Brazil.
https://orcid.org/0000-0002-4800-863X
Drª Cristina Dislich Ropke
Phytobios Ltda. Avenida Dr. Marcos Penteado de Ulhôa Rodrigues, 1119, room 607, Tamboré, CEP 05508-900, São Paulo, SP, Brazil.
https://orcid.org/0009-0002-5903-6297
Dr. Ana Cláudia Dias de Oliveira
Brazilian Association of Fine Chemical, Biotechnology and Specialty Industries – ABIFINA, Av. Churchill, 129, Room 1201, Centro, CEP 20020-050, Rio de Janeiro, RJ, Brazil; 2PhD Consulting, Rua Marquês de Abrantes, 19, Sala 901, Flamengo, CEP 22230-060, Rio de Janeiro, RJ, Brazil.
https://orcid.org/0000-0002-4250-1036
Dr. Celso Luiz Salgueiro Lage
National Institute of Industrial Property, DICOD - Academia. Praça Mauá 7, Room 1012, Centro, CEP 20081-240, Rio de Janeiro, RJ, Brazil.
https://orcid.org/0000-0002-3284-9469
Mrs. Barbara Sena Barbosa
Phytobios Ltda. Avenida Dr. Marcos Penteado de Ulhôa Rodrigues, 1119, room 607, Tam-boré, CEP 05508-900, São Paulo, SP, Brazil.
https://orcid.org/0009-0001-8780-9114